Compare Humana Inc (HUM) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Humana Inc trades at $406.15 (market cap $47.81B), while YieldMax MSTR Option Income Strategy ETF trades at $13.54. The key difference: Humana Inc pays a 0.89% dividend while YieldMax MSTR Option Income Strategy ETF pays none, and Humana Inc is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| HUM | MSTY | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $409.42 | $108.80 |
52-Week Low | $163.67 | $11.55 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
MSTY trades at $13.12, up 2.34% today, but remains in a bearish technical trend with significant price depreciation year-to-date. The ETF generates high weekly dividend distributions, but these are offset by substantial capital erosion, as highlighted by financial media. Key technical indicators signal selling pressure, with moving averages and oscillators predominantly bearish or neutral.
The outlook is cautious due to structural risks in the covered-call strategy capping upside potential while exposing investors to full downside. High distributions may not be sustainable if funded by return of capital. Investor sentiment is negative, with media reports emphasizing total return losses outweighing dividend income.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
